Strategy and Analysis of Investment Options for Global Pharmaceutical Company
A global pharmaceutical client was faced with a number of large, long-term infrastructure investment decisions to address a future revenue gap. Analysis Group reviewed existing opportunities, developed likely market scenarios, identified alternative strategic options including deferrable decisions, and evaluated the incremental financial benefits of elected options. Based on our analysis, the company decided to pursue the acquisition of a complementary franchise to grow its existing business in the short term, and to invest in selected capabilities and infrastructure to support the development of an ambitious early-stage pipeline.
Associated Experts & Staff